Skip to content

Homeopathic medicines for heel pain

A double-blind, randomized, placebo-controlled trial evaluating the efficacy of individualized homoeopathic medicine selected by using polarity analysis in improving chronic primary pain of heel in adults - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064630
Enrollment
74
Registered
2024-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M799- Soft tissue disorder, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering indicated homoeopathic remedy in centesimal potencies, as d
a special device that stretches the foot while you sleep, Use heel lifts or shoe inserts to reduce pain, avoiding lifting heavy weights, weight loss if obese, etc.
duration of treatment 3 months Control Intervention1: Identical-looking placebos plus concomitant care: This arm will receive placebo, indistinguishable in appearance from verum. Each dose of placebo
a special device that stretches the foot while you sleep, Use heel lifts or shoe inserts to reduce pain, avoiding lifting heavy weights, weight loss if obese, etc.

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with chronic primary pain of heel (ICD code- 11, MG 30.0). Heel pain persist for at least 3 months or more and absence of any bony deformity of foot on X-ray. 2. Age: 18 â?? 65years. 3. Patients of either sex including transgenders 4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of chronic primary pain of heel, provided the medications are stopped completely at least 2 weeks prior study entry. 5. Cases eligible for polarity analysis. Patient having at least 5 polar symptoms and 10 indicated remedies under a rubric.

Exclusion criteria

Exclusion criteria: 1. Not providing with informed consent voluntarily 2. Those cases suffering from uncontrolled systemic illness or life-threatening infections, suffering from calcaneal spur or any bony deformity or foot pathology. 3. Self-reported joint disorders (e.g., specific arthropathy, hyperuricaemia and/or gout, fracture or injury to the bones, bone tumour, joint or skin infections, joint prostheses of the lower limbs, rheumatoid arthritis) 4. Steroid injections within 2 weeks before study entry 5. Recent significant heel surgery within last 6 months 6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 7. Pregnancy, puerperium, lactation 8. Vulnerable population â?? Unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, mentally disabled people 9. Substance abuse and or dependence 10. Self-reported immune-compromised state 11. Undergoing homoeopathic treatment for any chronic disease within last 6 months, and 12. Simultaneous participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Foot Function Index (FFI)Timepoint: Every month, up to 3 months

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile (MYMOP-2)Timepoint: Every month, up to 3 months

Countries

India

Contacts

Public ContactRajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026